Thyroid failure in the elderly. Microsomal antibodies as discriminant for therapy

M. J. Rosenthal, W. C. Hunt, P. J. Garry, James Goodwin

Research output: Contribution to journalArticle

162 Citations (Scopus)

Abstract

Thyrotropin (thyroid-stimulating hormone [TSH]) levels were elevated above 4.0 mU/L (μU/mL) in serum samples from 13.2% of 258 healthy elderly subjects. To investigate the natural history of progressive thyroid failure, serial thyroid functions were measured for four years in 26 of these subjects with elevated TSH levels. In one third of these subjects, biochemical thyroid failure developed (thyroxine level<58 nmol/L [4.5 μg/dL]) within the course of the study. All subjects with initial TSH levels above 20 mU/L (μU/mL), and 80% of those with high-titer thyroid antimicrosomal antibodies (regardless of initial TSH level), became overtly hypothyroid. Compared with subjects with high-titer antibody, those with antibody titer less than 1:1600 had lower TSH and higher thyroxine levels, and thyroid failure developed in none during the study. These results suggest that among older patients with isolated elevations of the TSH level, only those with markedly elevated TSH levels or high-titer antimicrosomal antibodies should be prophylactically treated with levothyroxine sodium replacement.

Original languageEnglish (US)
Pages (from-to)209-213
Number of pages5
JournalJournal of the American Medical Association
Volume258
Issue number2
StatePublished - 1987
Externally publishedYes

Fingerprint

Thyrotropin
Thyroid Gland
Antibodies
Thyroxine
Therapeutics
Natural History
Healthy Volunteers
Serum

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Thyroid failure in the elderly. Microsomal antibodies as discriminant for therapy. / Rosenthal, M. J.; Hunt, W. C.; Garry, P. J.; Goodwin, James.

In: Journal of the American Medical Association, Vol. 258, No. 2, 1987, p. 209-213.

Research output: Contribution to journalArticle

@article{7cff7d5e971f4c6f8b714a4e59b64882,
title = "Thyroid failure in the elderly. Microsomal antibodies as discriminant for therapy",
abstract = "Thyrotropin (thyroid-stimulating hormone [TSH]) levels were elevated above 4.0 mU/L (μU/mL) in serum samples from 13.2{\%} of 258 healthy elderly subjects. To investigate the natural history of progressive thyroid failure, serial thyroid functions were measured for four years in 26 of these subjects with elevated TSH levels. In one third of these subjects, biochemical thyroid failure developed (thyroxine level<58 nmol/L [4.5 μg/dL]) within the course of the study. All subjects with initial TSH levels above 20 mU/L (μU/mL), and 80{\%} of those with high-titer thyroid antimicrosomal antibodies (regardless of initial TSH level), became overtly hypothyroid. Compared with subjects with high-titer antibody, those with antibody titer less than 1:1600 had lower TSH and higher thyroxine levels, and thyroid failure developed in none during the study. These results suggest that among older patients with isolated elevations of the TSH level, only those with markedly elevated TSH levels or high-titer antimicrosomal antibodies should be prophylactically treated with levothyroxine sodium replacement.",
author = "Rosenthal, {M. J.} and Hunt, {W. C.} and Garry, {P. J.} and James Goodwin",
year = "1987",
language = "English (US)",
volume = "258",
pages = "209--213",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "2",

}

TY - JOUR

T1 - Thyroid failure in the elderly. Microsomal antibodies as discriminant for therapy

AU - Rosenthal, M. J.

AU - Hunt, W. C.

AU - Garry, P. J.

AU - Goodwin, James

PY - 1987

Y1 - 1987

N2 - Thyrotropin (thyroid-stimulating hormone [TSH]) levels were elevated above 4.0 mU/L (μU/mL) in serum samples from 13.2% of 258 healthy elderly subjects. To investigate the natural history of progressive thyroid failure, serial thyroid functions were measured for four years in 26 of these subjects with elevated TSH levels. In one third of these subjects, biochemical thyroid failure developed (thyroxine level<58 nmol/L [4.5 μg/dL]) within the course of the study. All subjects with initial TSH levels above 20 mU/L (μU/mL), and 80% of those with high-titer thyroid antimicrosomal antibodies (regardless of initial TSH level), became overtly hypothyroid. Compared with subjects with high-titer antibody, those with antibody titer less than 1:1600 had lower TSH and higher thyroxine levels, and thyroid failure developed in none during the study. These results suggest that among older patients with isolated elevations of the TSH level, only those with markedly elevated TSH levels or high-titer antimicrosomal antibodies should be prophylactically treated with levothyroxine sodium replacement.

AB - Thyrotropin (thyroid-stimulating hormone [TSH]) levels were elevated above 4.0 mU/L (μU/mL) in serum samples from 13.2% of 258 healthy elderly subjects. To investigate the natural history of progressive thyroid failure, serial thyroid functions were measured for four years in 26 of these subjects with elevated TSH levels. In one third of these subjects, biochemical thyroid failure developed (thyroxine level<58 nmol/L [4.5 μg/dL]) within the course of the study. All subjects with initial TSH levels above 20 mU/L (μU/mL), and 80% of those with high-titer thyroid antimicrosomal antibodies (regardless of initial TSH level), became overtly hypothyroid. Compared with subjects with high-titer antibody, those with antibody titer less than 1:1600 had lower TSH and higher thyroxine levels, and thyroid failure developed in none during the study. These results suggest that among older patients with isolated elevations of the TSH level, only those with markedly elevated TSH levels or high-titer antimicrosomal antibodies should be prophylactically treated with levothyroxine sodium replacement.

UR - http://www.scopus.com/inward/record.url?scp=0023255773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023255773&partnerID=8YFLogxK

M3 - Article

C2 - 3599304

AN - SCOPUS:0023255773

VL - 258

SP - 209

EP - 213

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 2

ER -